LOINC Code 80386-6: Bladder tumor Ag IA.rapid Ql (U)
80386-6 is a LOINC code used to identify Bladder tumor Ag IA.rapid Ql (U) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Bladder tumor Ag. It is commonly used with the system or sample type Urine.
What is this code?
LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Bladder tumor Ag. It is commonly used with the system or sample type Urine.
When is it used?
- Used in lab systems, EHRs, and clinical data exchange.
- May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
- Status: ACTIVE
- Order vs observation: Both
- Method: IA.rapid
What it does not mean
- The code identifies the observation or test, not the actual result.
Key facts
- Bladder tumor Ag [Presence] in Urine by Rapid immunoassay
- Bladder tumor Ag
- This term was created for, but is not limited in use to, the bioMerieux bioNexia BTA assay, which is intended for the qualitative detection of bladder tumor-associated antigen (BTA) in human urine specimens. The test is indicated for use as an aid for screening high-risk populations and monitoring bladder cancer patients. The bioNexia BTA assay results should be read 5-6 minutes after the sample is applied to the sample well.
- Antigen; Antigens; BT; BTA; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SUDS; Tumor marker; UA; UR; Urn
Where you may see this code
You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.